Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3>Scutellaria (Lamiaceae), which includes 536 accepted species, is widespread in Europe, North America, East Asia, and South America. Several species are used as traditional medicines for a long history to treat diarrhea, dysentery, inflammation, respiratory infections. The phytochemistry and pharmacology of the genus Scutellaria have developed dramatically in the past ten years, and the traditional uses and clinical studies of the genus have not been systematically summarized. Therefore, it is especially valuable to exhibit its current progress to provide the bases for further exploration of medicinal potential.Aim of the review: The aim of the review is to provide updated information on the ethnopharmacology and clinical studies, the ten-years research progress of phytochemistry and pharmacology of Scutellaria, and to explore the potential medicinal values and further studies of Scutellaria.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3>This review is based on the literature studies and books from the library and electronic sources, including SciFinder, Scopus, PubMed, Web of Science, Baidu Scholar, CNKI, online ethnobotanical database, and ethnobotanical monographs. These literature are related to ethnopharmacology, clinical studies, the ten-years research progress of phytochemistry, and pharmacology of Scutellaria.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3>A total of 52 species and 20 varieties of the genus Scutellaria are used as traditional medicine with various biological activities. In the past ten years, 208 chemical constituents have been identified from 16 species and 1 variety of the genus Scutellaria, such as neo-clerodane diterpenoids, sesterterpenoids, terpenoid, flavonoids. Currently, pharmacological researches have demonstrated that the extract and compound identified from this genus exhibited extensive biological activities, including anticancer, antioxidant, anti-inflammatory, antiviral activities, anti-bacterial, effects on cardiovascular and cerebrovascular diseases, hepatoprotective and effects on neurodegenerative disease. The species of S. baicalensis, S. barbata, and S. lateriflora and the main compounds baicalein, baicalin and wogonin are involved in clinical trials, which point the way for us to conduct further study including anticancer, lower blood pressure, anti-infective, anti-inflammatory, protect the central nervous system and other effects on Scutellaria.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3>The species in Scutellaria can be used to treat cancer, infection, hepatic disorders, cardiovascular and cerebrovascular diseases, neurodegenerative diseases and other diseases. Some indications in traditional medicines have been confirmed by modern pharmacological activities, such as anticancer, anti-inflammatory, anti-infective, hepatoprotective, and neuroprotection. The available literature exhibited that most of the bioactivities could be attributed to flavonoids and neo-clerodane diterpenoids. Though there are some in clinical practice of Scutellaria, the existing researches on this genus is still limited. For more profound studies of Scutellaria, in-depth study of more concerned species, which possess great bioactivities to treat diseases in vitro/vivo and as well as in clinical are suggested to be carried out to complete the studies on their effective substances, pharmacology mechanism, quality control, clinical use, and new drug research. Also, in order to expand the development of medicinal resources of Scutellaria, the once used as local herbal medicine but unexploited species are needed more concern.

Medicinal Ethnic Botany Research of Swertia Genus

Review on Saussurea laniceps, a potent medicinal plant known as “snow lotus”: botany, phytochemistry and bioactivities

Swertia L.: A comprehensive review of its genetic relationship, chemical compositions, pharmacological effects, toxicities, and applications

Phytochemistry and Pharmacological Activities of the Genus Swertia (Gentianaceae): A Review

Application of Microscopy for Discrimination of Eight Swertia Species Utilized in the Traditional Chinese Medicine "Qingyedan".

Recent Progress of Research on Medicinal Mushrooms, Foods, and Other Herbal Products Used in Traditional Chinese Medicine

[Preliminary comparative study of swertiamarin and swertisin on three kinds of Digeda-species Mongolian medicinal materials].

Recent advances in Scutellariae radix: A comprehensive review on ethnobotanical uses, processing, phytochemistry, pharmacological effects, quality control and influence factors of biosynthesis

Pharmacophylogenetic insights into Scutellaria strigillosa Hemsl.: chloroplast genome and untargeted metabolomics, quantitative analysis and antibacterial analysis

Geographical equations of Swertia mussotii bioactivities: evidence from the western Sichuan region of China

Fingerprint Analysis of Chemical Constituents of Swertia patens

Ethnobotanical study on medicinal plants used by Bulang people in Yunnan, China

Traditional uses, ten-years research progress on phytochemistry and pharmacology, and clinical studies of the genus Scutellaria

Secoiridoids from the traditional Chinese medicine Swertia pseudochinensis

Genotyping-by-sequencing to determine the genetic structure of a Tibetan medicinal plant Swertia mussotii Franch.

Diversity and traditional knowledge of medicinal plants used by Shui people in Southwest China

Advances in pharmacology, biosynthesis, and metabolic engineering of Scutellaria-specialized metabolites

Ethnomedicine study on traditional medicinal plants in the Wuliang Mountains of Jingdong, Yunnan, China

Study on the Tibetan Medicine Swertia Mussotii Franch and Its Extracts by Fourier Transform Infrared Spectroscopy

Chemical Constituents from Swertia Mussotii Franch. (Gentianaceae)

Metabolomics‐based pharmaceutical evaluation of different parts of Swertia chirayita (Roxb.) Buch.‐Ham. ex C.B. Clarke from the western Himalayas